Skip to main content
Top
Published in: Current Pulmonology Reports 1/2017

01-03-2017 | Nutrition and Clinical Care (J Patel, Section Editor)

Persistent, Immunosuppression, Inflammation, Catabolism Syndrome and Diaphragmatic Dysfunction

Authors: Martin D. Rosenthal, Cameron M. Rosenthal, Frederick A. Moore, Robert G. Martindale

Published in: Current Pulmonology Reports | Issue 1/2017

Login to get access

Abstract

Purpose of review

The purpose of this review is to explore the relationship between ICU-acquired weakness, diaphragm dysfunction, and persistent immunosuppression, inflammation, catabolism syndrome (PICS), as well as if there are any therapies that can help rehabilitate these patients.

Recent findings

Literature pertaining to PICS is scant, as it is a relatively new description of encompassing chronic multiorgan dysfunction and chronic critical illness. PICS patients invariably have persistent diaphragm dysfunction and ICU-acquired weakness. To better understand how severe each state is and how they are related, the literature was reviewed.

Summary

Combating diaphragm dysfunction, ICU-acquired weakness, and PICS is a difficult task for intensivists. There are certain nutritional supplements that can help rehabilitate these patients, but there is no silver bullet right now. Helping these patients currently takes a multimodal approach.
Literature
1.
go back to reference • Kress JP, Hall JB. ICU-acquired weakness and recovery from critical illness. N Engl J Med. 2014;370(17):1626–35. Kress publication in NEJM is a complete review of ICUAW and what it means for critically ill patients’ recovery/rehab potential.PubMedCrossRef • Kress JP, Hall JB. ICU-acquired weakness and recovery from critical illness. N Engl J Med. 2014;370(17):1626–35. Kress publication in NEJM is a complete review of ICUAW and what it means for critically ill patients’ recovery/rehab potential.PubMedCrossRef
2.
go back to reference Fan E, Cheek F, Chlan L, Gosselink R, Hart N, Herridge MS, et al. An official American Thoracic Society Clinical Practice guideline: the diagnosis of intensive care unit-acquired weakness in adults. Am J Respir Crit Care Med. 2014;190(12):1437–46.PubMedCrossRef Fan E, Cheek F, Chlan L, Gosselink R, Hart N, Herridge MS, et al. An official American Thoracic Society Clinical Practice guideline: the diagnosis of intensive care unit-acquired weakness in adults. Am J Respir Crit Care Med. 2014;190(12):1437–46.PubMedCrossRef
3.
go back to reference Eikermann M, Latronico N. What is new in prevention of muscle weakness in critically ill patients? Intensive Care Med. 2013;39(12):2200–3.PubMedCrossRef Eikermann M, Latronico N. What is new in prevention of muscle weakness in critically ill patients? Intensive Care Med. 2013;39(12):2200–3.PubMedCrossRef
4.
go back to reference Rosenthal, M., A. Gabrielli, and F. Moore, The evolution of nutritional support in long term ICU patients: from multisystem organ failure to persistent inflammation immunosuppression catabolism syndrome. Minerva Anestesiol, 2015. Rosenthal, M., A. Gabrielli, and F. Moore, The evolution of nutritional support in long term ICU patients: from multisystem organ failure to persistent inflammation immunosuppression catabolism syndrome. Minerva Anestesiol, 2015.
5.
go back to reference Rosenthal MD, Moore FA. Persistent inflammatory, immunosuppressed, catabolic syndrome (PICS): a new phenotype of multiple organ failure. J Adv Nutr Hum Metab, 2015;1(1). Rosenthal MD, Moore FA. Persistent inflammatory, immunosuppressed, catabolic syndrome (PICS): a new phenotype of multiple organ failure. J Adv Nutr Hum Metab, 2015;1(1).
6.
go back to reference De Jonghe B, Bastuji-Garin S, Sharshar T, Outin H, Brochard L. Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med. 2004;30(6):1117–21.PubMedCrossRef De Jonghe B, Bastuji-Garin S, Sharshar T, Outin H, Brochard L. Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med. 2004;30(6):1117–21.PubMedCrossRef
7.
go back to reference De Jonghe B, Sharshar T, Hopkinson N, Outin H. Paresis following mechanical ventilation. Curr Opin Crit Care. 2004;10(1):47–52.PubMedCrossRef De Jonghe B, Sharshar T, Hopkinson N, Outin H. Paresis following mechanical ventilation. Curr Opin Crit Care. 2004;10(1):47–52.PubMedCrossRef
8.
go back to reference •• Vanzant EL, Lopez CM, Ozrazgat-Baslanti T, Ungaro R, Davis R, Cuenca AG, Gentile LF, Nacionales DC, Cuenca AL, Bihorac A, Leeuwenburgh C, Lanz J, Baker HV, McKinley B, Moldawer LL, Moore FA, Efron PA. Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma. J Trauma Acute Care Surg. 2014. 76(1): p. 21–9; discussion 29–30. Moore et al. have a current P50 grant studying PICS. There are three specific aims of the P50 grant that allow them to better understand the epidemiology and pathophysiology that produce a PICS patient. Through innovative research, they hope to find potential therapeutic interventions for PICS patients.PubMedCrossRef •• Vanzant EL, Lopez CM, Ozrazgat-Baslanti T, Ungaro R, Davis R, Cuenca AG, Gentile LF, Nacionales DC, Cuenca AL, Bihorac A, Leeuwenburgh C, Lanz J, Baker HV, McKinley B, Moldawer LL, Moore FA, Efron PA. Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma. J Trauma Acute Care Surg. 2014. 76(1): p. 21–9; discussion 29–30. Moore et al. have a current P50 grant studying PICS. There are three specific aims of the P50 grant that allow them to better understand the epidemiology and pathophysiology that produce a PICS patient. Through innovative research, they hope to find potential therapeutic interventions for PICS patients.PubMedCrossRef
9.
go back to reference Gentile LF, Cuenca AG, Efron PA, Ang D, Bihorac A, McKinley BA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg. 2012;72(6):1491–501.PubMedPubMedCentralCrossRef Gentile LF, Cuenca AG, Efron PA, Ang D, Bihorac A, McKinley BA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg. 2012;72(6):1491–501.PubMedPubMedCentralCrossRef
10.
go back to reference Puthucheary ZA, Rawal J, McPhail M, Connolly B, Ratnayake G, Chan P, et al. Acute skeletal muscle wasting in critical illness. JAMA. 2013;310(15):1591–600.PubMedCrossRef Puthucheary ZA, Rawal J, McPhail M, Connolly B, Ratnayake G, Chan P, et al. Acute skeletal muscle wasting in critical illness. JAMA. 2013;310(15):1591–600.PubMedCrossRef
11.
go back to reference Medrinal C, Prieur G, Frenoy E, Robledo Quesada A, Poncet A, Bonnevie T, et al. Respiratory weakness after mechanical ventilation is associated with one-year mortality—a prospective study. Crit Care. 2016;20(1):231.PubMedPubMedCentralCrossRef Medrinal C, Prieur G, Frenoy E, Robledo Quesada A, Poncet A, Bonnevie T, et al. Respiratory weakness after mechanical ventilation is associated with one-year mortality—a prospective study. Crit Care. 2016;20(1):231.PubMedPubMedCentralCrossRef
12.
go back to reference Jung B, Gleeton D, Daurat A, Conseil M, Mahul M, Rao G, et al. Consequences of mechanical ventilation on diaphragmatic function. Rev Mal Respir. 2015;32(4):370–80.PubMedCrossRef Jung B, Gleeton D, Daurat A, Conseil M, Mahul M, Rao G, et al. Consequences of mechanical ventilation on diaphragmatic function. Rev Mal Respir. 2015;32(4):370–80.PubMedCrossRef
13.
go back to reference Jung B, Moury PH, Mahul M, de Jong A, Galia F, Prades A, et al. Diaphragmatic dysfunction in patients with ICU-acquired weakness and its impact on extubation failure. Intensive Care Med. 2016;42(5):853–61.PubMedCrossRef Jung B, Moury PH, Mahul M, de Jong A, Galia F, Prades A, et al. Diaphragmatic dysfunction in patients with ICU-acquired weakness and its impact on extubation failure. Intensive Care Med. 2016;42(5):853–61.PubMedCrossRef
14.
go back to reference Hermans G, Van Mechelen H, Clerckx B, Vanhullebusch T, Mesotten D, Wilmer A, et al. Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2014;190(4):410–20.PubMedCrossRef Hermans G, Van Mechelen H, Clerckx B, Vanhullebusch T, Mesotten D, Wilmer A, et al. Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2014;190(4):410–20.PubMedCrossRef
15.
go back to reference Martin AD, Smith BK, Davenport PD, Harman E, Gonzalez-Rothi RJ, Baz M, et al. Inspiratory muscle strength training improves weaning outcome in failure to wean patients: a randomized trial. Crit Care. 2011;15(2):R84.PubMedPubMedCentralCrossRef Martin AD, Smith BK, Davenport PD, Harman E, Gonzalez-Rothi RJ, Baz M, et al. Inspiratory muscle strength training improves weaning outcome in failure to wean patients: a randomized trial. Crit Care. 2011;15(2):R84.PubMedPubMedCentralCrossRef
16.
go back to reference Daniel Martin A, Smith BK, Gabrielli A. Mechanical ventilation, diaphragm weakness and weaning: a rehabilitation perspective. Respir Physiol Neurobiol. 2013;189(2):377–83.PubMedCrossRef Daniel Martin A, Smith BK, Gabrielli A. Mechanical ventilation, diaphragm weakness and weaning: a rehabilitation perspective. Respir Physiol Neurobiol. 2013;189(2):377–83.PubMedCrossRef
17.
go back to reference De Jonghe B, Bastuji-Garin S, Durand MC, Malissin I, Rodrigues P, Cerf C, et al. Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med. 2007;35(9):2007–15.PubMedCrossRef De Jonghe B, Bastuji-Garin S, Durand MC, Malissin I, Rodrigues P, Cerf C, et al. Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med. 2007;35(9):2007–15.PubMedCrossRef
19.
go back to reference Serhan CN, Krishnamoorthy S, Recchiuti A, Chiang N. Novel anti-inflammatory—pro-resolving mediators and their receptors. Curr Top Med Chem. 2011;11(6):629–47.PubMedPubMedCentralCrossRef Serhan CN, Krishnamoorthy S, Recchiuti A, Chiang N. Novel anti-inflammatory—pro-resolving mediators and their receptors. Curr Top Med Chem. 2011;11(6):629–47.PubMedPubMedCentralCrossRef
20.
go back to reference Luiking YC, Poeze M, Dejong CH, Ramsay G, Deutz NE. Sepsis: an arginine deficiency state? Crit Care Med. 2004;32(10):2135–45.PubMedCrossRef Luiking YC, Poeze M, Dejong CH, Ramsay G, Deutz NE. Sepsis: an arginine deficiency state? Crit Care Med. 2004;32(10):2135–45.PubMedCrossRef
21.
go back to reference Taheri F, Ochoa JB, Faghiri Z, Culotta K, Park HJ, Lan MS, et al. L-Arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells. Clin Cancer Res. 2001;7(3 Suppl):958s-965s.PubMed Taheri F, Ochoa JB, Faghiri Z, Culotta K, Park HJ, Lan MS, et al. L-Arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells. Clin Cancer Res. 2001;7(3 Suppl):958s-965s.PubMed
22.
go back to reference Rodriguez PC, Zea AH, Culotta KS, Zabaleta J, Ochoa JB, Ochoa AC. Regulation of T cell receptor CD3zeta chain expression by L-arginine. J Biol Chem. 2002;277(24):21123–9.PubMedCrossRef Rodriguez PC, Zea AH, Culotta KS, Zabaleta J, Ochoa JB, Ochoa AC. Regulation of T cell receptor CD3zeta chain expression by L-arginine. J Biol Chem. 2002;277(24):21123–9.PubMedCrossRef
23.
go back to reference Rodriguez PC, Zea AH, DeSalvo J, Culotta KS, Zabaleta J, Quiceno DG, et al. L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol. 2003;171(3):1232–9.PubMedCrossRef Rodriguez PC, Zea AH, DeSalvo J, Culotta KS, Zabaleta J, Quiceno DG, et al. L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol. 2003;171(3):1232–9.PubMedCrossRef
24.
go back to reference Zea AH, Rodriguez PC, Culotta KS, Hernandez CP, DeSalvo J, Ochoa JB, et al. L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. Cell Immunol. 2004;232(1–2):21–31.PubMedCrossRef Zea AH, Rodriguez PC, Culotta KS, Hernandez CP, DeSalvo J, Ochoa JB, et al. L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. Cell Immunol. 2004;232(1–2):21–31.PubMedCrossRef
25.
go back to reference Makarenkova VP, Bansal V, Matta BM, Perez LA, Ochoa JB. CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol. 2006;176(4):2085–94.PubMedCrossRef Makarenkova VP, Bansal V, Matta BM, Perez LA, Ochoa JB. CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol. 2006;176(4):2085–94.PubMedCrossRef
26.
go back to reference Scumpia PO, Delano MJ, Kelly-Scumpia KM, Weinstein JS, Wynn JL, Winfield RD, et al. Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood. 2007;110(10):3673–81.PubMedPubMedCentralCrossRef Scumpia PO, Delano MJ, Kelly-Scumpia KM, Weinstein JS, Wynn JL, Winfield RD, et al. Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood. 2007;110(10):3673–81.PubMedPubMedCentralCrossRef
27.
28.
go back to reference Zhu X, Pribis JP, Rodriguez PC, Morris Jr SM, Vodovotz Y, Billiar TR, et al. The central role of arginine catabolism in T-cell dysfunction and increased susceptibility to infection after physical injury. Ann Surg. 2014;259(1):171–8.PubMedCrossRef Zhu X, Pribis JP, Rodriguez PC, Morris Jr SM, Vodovotz Y, Billiar TR, et al. The central role of arginine catabolism in T-cell dysfunction and increased susceptibility to infection after physical injury. Ann Surg. 2014;259(1):171–8.PubMedCrossRef
29.
go back to reference Bansal V, Ochoa JB. Arginine availability, arginase, and the immune response. Curr Opin Clin Nutr Metab Care. 2003;6(2):223–8.PubMedCrossRef Bansal V, Ochoa JB. Arginine availability, arginase, and the immune response. Curr Opin Clin Nutr Metab Care. 2003;6(2):223–8.PubMedCrossRef
30.
go back to reference Daly JM, Reynolds J, Thom A, Kinsley L, Dietrick-Gallagher M, Shou J, et al. Immune and metabolic effects of arginine in the surgical patient. Ann Surg. 1988;208(4):512–23.PubMedPubMedCentralCrossRef Daly JM, Reynolds J, Thom A, Kinsley L, Dietrick-Gallagher M, Shou J, et al. Immune and metabolic effects of arginine in the surgical patient. Ann Surg. 1988;208(4):512–23.PubMedPubMedCentralCrossRef
31.
go back to reference Barbul A, Sisto DA, Wasserkrug HL, Efron G. Arginine stimulates lymphocyte immune response in healthy human beings. Surgery. 1981;90(2):244–51.PubMed Barbul A, Sisto DA, Wasserkrug HL, Efron G. Arginine stimulates lymphocyte immune response in healthy human beings. Surgery. 1981;90(2):244–51.PubMed
32.
go back to reference Morris Jr SM. Arginine: master and commander in innate immune responses. Sci Signal. 2010;3(135):pe27.PubMedCrossRef Morris Jr SM. Arginine: master and commander in innate immune responses. Sci Signal. 2010;3(135):pe27.PubMedCrossRef
33.
go back to reference Barbul A, Rettura G, Levenson SM, Seifter E. Arginine: a thymotropic and wound-healing promoting agent. Surg Forum. 1977;28:101–3.PubMed Barbul A, Rettura G, Levenson SM, Seifter E. Arginine: a thymotropic and wound-healing promoting agent. Surg Forum. 1977;28:101–3.PubMed
34.
go back to reference Barbul A, Wasserkrug HL, Sisto DA, Seifter E, Rettura G, Levenson SM, et al. Thymic stimulatory actions of arginine. JPEN J Parenter Enteral Nutr. 1980;4(5):446–9.PubMedCrossRef Barbul A, Wasserkrug HL, Sisto DA, Seifter E, Rettura G, Levenson SM, et al. Thymic stimulatory actions of arginine. JPEN J Parenter Enteral Nutr. 1980;4(5):446–9.PubMedCrossRef
Metadata
Title
Persistent, Immunosuppression, Inflammation, Catabolism Syndrome and Diaphragmatic Dysfunction
Authors
Martin D. Rosenthal
Cameron M. Rosenthal
Frederick A. Moore
Robert G. Martindale
Publication date
01-03-2017
Publisher
Springer US
Published in
Current Pulmonology Reports / Issue 1/2017
Electronic ISSN: 2199-2428
DOI
https://doi.org/10.1007/s13665-017-0166-z

Other articles of this Issue 1/2017

Current Pulmonology Reports 1/2017 Go to the issue

Pleural Diseases and Mesothelioma (G Lee, Section Editor)

Cytological diagnosis of malignant pleural mesothelioma

Pleural Diseases and Mesothelioma (G Lee, Section Editor)

Thoracic Ultrasound: What Non-radiologists Need to Know

Nutrition and Clinical Care (J Patel, Section Editor)

Idiopathic Pleuroparenchymal Fibroelastosis

Pleural Diseases and Mesothelioma (G Lee, Section Editor)

Blood Patch for Pneumothorax: a Literature Review

Nutrition and Clinical Care (J Patel, Section Editor)

Optimizing Enteral Nutrition in Medical Intensive Care Patients

Nutrition and Clinical Care (J Patel, Section Editor)

Identifying nutritional risk in critical illness